ICD and CRT-D device registry for patients worldwide
Part of Heart & circulation clinical trials.
This trial is a real-world registry that collects information from people who receive an implantable heart defibrillator or related device. It helps doctors understand how these devices are used and how patients do over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have an ICD or CRT-D implanted (for the first time) or have a battery (generator) replaced
- You receive the device for prevention—either because you had a heart rhythm problem before or to prevent one from happening
- You are also eligible if you have a lead-only procedure for an ICD or CRT-D
- If you’re in the U.S. and getting an ICD for primary prevention and you’re on Medicare, your information must be submitted for the study
- No specific health conditions are listed as exclusions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This registry study follows patients who have or will get a CCM device to see how well it works and how safe it is over time. It helps doctors learn more about improving heart function in people with heart failure.
This study looks at whether implantable defibrillators can reduce dangerous heart rhythms in people with non-ischemic cardiomyopathy (heart weakness not caused by blocked heart arteries), a heart scar, and very low pumping strength despite best treatment. It compares different approaches to choosing which patients should receive these devices.
This study collects information from people who have a heart device (like a pacemaker) to learn how these devices work in real life and how they affect patients. By joining, you help doctors improve care for future patients.
This study is testing a new type of implantable cardioverter-defibrillator (ICD) or cardiac resynchronization therapy defibrillator (CRT-D) called the CorSky Family. The goal is to see how well it works for people who need a device to help their heart pump properly and prevent dangerous rhythms.
This study is a registry that collects information from people with arrhythmogenic cardiomyopathy who have an ICD. The goal is to learn more about the condition, its heart rhythm complications, and how the ICD works, which may help improve future care.
This study tests a heart failure alert system called HeartInsight in people who recently received an ICD or CRT-D device. The goal is to see if the alerts help doctors manage care better. You may qualify if you got a new (not replacement) device less than a year ago.
Hear when a new Heart failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.